Original paper
NFκB activation demarcates a subset of hepatocellular carcinoma patients for targeted therapy
Abstract
Background
Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading cause of cancer death worldwide. It is a heterogeneous disorder and >80 % of the tumors develop in patients with liver cirrhosis, resulting from chronic inflammation and/or fibrosis. Here, we set out to identify novel targets for HCC therapy and to define a subgroup of patients that might benefit most from...
Paper Details
Title
NFκB activation demarcates a subset of hepatocellular carcinoma patients for targeted therapy
Published Date
Aug 25, 2016
Journal
Volume
39
Issue
6
Pages
523 - 536
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History